Pan-cancer landscape of cellular senescence heterogeneity reveals associations with prognosis and therapy response
8.5
来源：
Nature
关键字：
ML brain science
发布时间：
2025-11-13 07:38
摘要：
This comprehensive study explores the heterogeneity of cellular senescence across 33 cancer types, identifying five distinct subgroups with unique biological characteristics and prognostic implications. The findings suggest that these subgroups can enhance personalized therapeutic strategies, particularly in immunotherapy. The research also highlights potential therapeutic targets and agents, making it relevant for future investment in oncology.
原文：
查看原文
价值分投票
评分标准
新闻价值分采用0-10分制，综合考虑新闻的真实性、重要性、时效性、影响力等多个维度。
评分越高，表示该新闻的价值越大，越值得关注。
价值维度分析
domain_focus
1.0分+1.0分
business_impact
0.8分+0.8分
scientific_rigor
1.5分+1.5分
timeliness_innovation
1.5分+1.5分
investment_perspective
2.5分+2.5分
market_value_relevance
1.0分+1.0分
team_institution_background
0.5分+0.5分
technical_barrier_competition
1.0分+1.0分
关键证据
Identified five distinct cellular senescence subgroups with significant associations with cancer prognosis.
Developed a machine-learning model to predict immunotherapy response based on cellular senescence-related genes.
Potential therapeutic agents and targets were identified for each senescence subgroup.
真实性检查
否
AI评分总结
This comprehensive study explores the heterogeneity of cellular senescence across 33 cancer types, identifying five distinct subgroups with unique biological characteristics and prognostic implications. The findings suggest that these subgroups can enhance personalized therapeutic strategies, particularly in immunotherapy. The research also highlights potential therapeutic targets and agents, making it relevant for future investment in oncology.